Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis?

Cambridge University spin-out company LIFNano is pioneering a new approach to the treatment of multiple sclerosis (MS) by using nanotechnology to deliver proteins that could ‘flip a switch’ in the brain. Abi Millar asks founder Dr Su Metcalfe about the breakthrough, and its chances of revolutionising treatment for MS patients.

Go Top